Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase

Oncogene

Volumn 34, Issue 26, 2015, Pages 3429-3440

  Chaturvedi, R ^a   De Sablet, T ^a   Asim, M ^a   Piazuelo, M B ^a   Barry, D P ^a   Verriere, T G ^a   Sierra, J C ^a   Hardbower, D M ^a,b   Delgado, A G ^a   Schneider, B G ^a   Israel, D A ^a   Romero Gallo, J ^a   Nagy, T A ^a   Morgan, D R ^a   Murray Stewart, T ^c   Bravo, L E ^d   Peek, R M ^a,b   Fox, J G ^e   Woster, P M ^f   Casero, R A ^c   Correa, P ^a   Wilson, K T ^a,b,g   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSIDAD DEL VALLE   (Colombia)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; EFLORNITHINE; N,N' BIS(2,3 BUTADIENYL)PUTRESCINE; ONCOPROTEIN; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASE; SPERMINE OXIDASE; UNCLASSIFIED DRUG; HYDROGEN PEROXIDE; POLYAMINE OXIDASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL GENE; BACTERIAL STRAIN; CANCER PREVENTION; CANCER RISK; COCULTURE; COLOMBIA; CONTROLLED STUDY; DNA DAMAGE; DYSPLASIA; EPITHELIUM CELL; FLOW CYTOMETRY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW RISK POPULATION; MALE; MERIONES UNGUICULATUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; ADENOCARCINOMA; ANIMAL; CELL CULTURE; COMPLICATION; ENZYME INDUCTION; GENETICS; GERBIL; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; STOMACH NEOPLASMS;

GERBILLINAE; HELICOBACTER PYLORI; MERIONES UNGUICULATUS;

ADENOCARCINOMA; ADULT; ANIMALS; CELLS, CULTURED; COLOMBIA; DNA DAMAGE; ENZYME INDUCTION; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84933041264     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.273     Document Type: Article

References (55)

1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
4. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560.
5. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G et al. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990; 50: 4731-4736.
6. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010; 105: 493-498.
7. de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011; 60: 1189-1195.
8. Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martinez E, Greenberg ER et al. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA 2013; 309: 578-586.
9. You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS et al. Randomized doubleblind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-983.
10. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104: 488-492.
11. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA 2004; 291: 187-194.
12. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198: 553-560.
13. Koike T, Ohara S, Sekine H, Iijima K, Kato K, Shimosegawa T et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999; 94: 3468-3472.
14. Torres J, Correa P, Ferreccio C, Hernandez-Suarez G, Herrero R, Cavazza-Porro M et al. Gastric cancer incidence and mortality is associated with altitude in themountainous regions of Pacific Latin America. Cancer Causes Control 2013; 24: 249-256.
15. Dominguez RL, Crockett SD, Lund JL, Suazo LP, Heidt P, Martin C et al. Gastric cancer incidence estimation in a resource-limited nation: use of endoscopy registry methodology. Cancer Causes Control 2013; 24: 233-239.
16. Cuello C, Correa P, Haenszel W, Gordillo G, Brown C, Archer M et al. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst 1976; 57: 1015-1020.
17. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976; 57: 1027-1035.
18. Bravo LE, van Doom LJ, Realpe JL, Correa P. Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma? Am J Gastroenterol 2002; 97: 2839-2842.
19. Wroblewski LE, Peek Jr RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010; 23: 713-739.
20. Peek Jr RM, Fiske C, Wilson KT. Role of innate immunity in Helicobacter pyloriinduced gastric malignancy. Physiol Rev 2010; 90: 831-858.
21. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135: 91-99.
22. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115.
23. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687.
24. Chaturvedi R, Cheng Y, Asim M, Bussiere FI, Xu H, Gobert AP et al. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem 2004; 279: 40161-40173.
25. Chaturvedi R, Asim M, Hoge S, Lewis ND, Singh K, Barry DP et al. Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production. Gastroenterology 2010; 139: 1686-1698.
26. Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, Yao MD et al. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004; 64: 8521-8525.
27. Chaturvedi R, Asim M, Romero-Gallo J, Barry DP, Hoge S, de Sablet T et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 2011; 141: e1691-e1692.
28. Hardbower DM, de Sablet T, Chaturvedi R, Wilson KT. Chronic inflammation and oxidative stress: The smoking gun for Helicobacter pylori-induced gastric cancer? Gut Microbes 2013; 4: 475-481.
29. Chaturvedi R, Asim M, Piazuelo MB, Yan F, Barry DP, Sierra JC et al. Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Gastroenterology 2014; 146: e1714.
30. Tammer I, Brandt S, Hartig R, Konig W, Backert S. Activation of Abl by Helicobacter pylori: A novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 2007; 132: 1309-1319.
31. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001; 42: 631-644.
32. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795.
33. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002; 99: 14428-14433.
34. Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S et al. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006; 130: 1181-1190.
35. Sicinschi LA, Correa P, Peek RM, Camargo MC, Piazuelo MB, Romero-Gallo J, et al. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect 2010; 16: 369-378.
36. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 642-648.
37. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 2008; 68: 379-387.
38. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB et al. Activation of {beta}-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 2005; 102: 10646-10651.
39. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylori CagA × SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003; 278: 3664-3670.
40. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 2008; 27: 1671-1681.
41. Babbar N, Casero Jr RA. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: A potential mechanism for inflammation-induced carcinogenesis. Cancer Res 2006; 66: 11125-11130.
42. Sheh A, Chaturvedi R, Merrell DS, Correa P, Wilson KT, Fox JG. Phylogeographic origin of Helicobacter pylori determines host-adaptive responses upon coculture with gastric epithelial cells. Infect Immun 2013; 81: 2468-2477.
43. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
44. Valentin-Vega YA, Okano H, Lozano G. The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival. Cell Death Differ 2008; 15: 1772-1781.
45. Kodaman N, Pazos A, Schneider BG, Piazuelo MB, Mera R, Sobota RS et al. Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci USA 2014; 111: 1455-1460.
46. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-1540.
47. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial. Cancer Prev Res (Philadlphia, PA) 2008; 1: 9-11.
48. Zell JA, McLaren CE, Chen WP, Thompson PA, Gerner EW, Meyskens FL. Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J Natl Cancer Inst 2010; 102: 1513-1516.
49. Basu HS, Thompson TA, Church DR, Clower CC, Mehraein-Ghomi F, Amlong CA et al. A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model. Cancer Res 2009; 69: 7689-7695.
50. Tummuru MK, Cover TL, Blaser MJ. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun 1994; 62: 2609-2613.
51. Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek Jr RM. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis 2009; 199: 641-651.
52. Zabaleta J, Camargo MC, Piazuelo MB, Fontham E, Schneider BG, Sicinschi LA et al. Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol 2006; 101: 163-171.
53. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
54. Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 15354-15359.
55. Casero RA Jr, Celano P, Ervin SJ, Porter CW, Bergeron RJ, Libby PR. Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res 1989; 49: 3829-3833.